500 patients67,039 observations150 daysLIVE

Patient P-03444

Synthetic patientONX-7 · Day 148 · 45–54 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Improving
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
56%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S17
  2. Day 103 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 103.

Primary contributors, last 14 days
  • GI instability-7
  • Treatment adherence-4
  • Toxicity+4
  • Inflammatory activity+3

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    58%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 82% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    2.7/10
    stable · -0.0 vs previous 14 d
    Stress level
    Daily log
    7.1/10
    stable · -0.1 vs previous 14 d
    Pessimism score
    Daily log
    5.5/10
    stable · -0.0 vs previous 14 d
    Sleep quality
    Wearable
    25.6/100
    improving · +3.0 vs previous 14 d
    Libido
    Daily log
    2.4/10
    stable · -0.1 vs previous 14 d
    HRV
    Wearable
    31 ms
    stable · +1.0 vs previous 14 d
    Toxicity
    Blood
    50/100
    stable · +1.5 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 40 from the failing basin, 56 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +5.5
    • Protein
      supporter · GI -3.6 next day
    Main detractors to watch
    • Rapid metabolizer
      hidden · steering -8
    • Enterobacteriaceae elevated
      hidden · steering -7.4
    • Lactose
      perturbation · steering -6.2
    • Antibiotic course
      perturbation · steering -4.7
    • Lactose
      detractor · GI +3.1 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.6supporter · 95%
    • Lactose
      +3.1detractor · 95%
    • Histamine load
      -0.9no signal · 27%
    • Alcohol
      +0.9no signal · 23%
    • Caffeine
      +0.4no signal · 15%
    • Dietary fat load
      +0.3no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Drug metabolism and exposure 55
      • DNADPYD *2A → slower clearance
      • BloodToxicity index 50
    • Mucosal barrier integrity 50
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 56 and rising
    • Butyrate / short-chain fatty acid production 45
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Inflammatory signalling 40
      • BloodInflammatory load index 60
      • WearableHRV 31 ms, trending down
    • Autonomic recovery 25
      • WearableResting HR 86 bpm
    DNA
    Fictional pharmacogenomic panel
    • DPYD *2A heterozygous
      Slower drug clearance
    • CYP2D6 Rapid metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 3 · butyrate capacity 47/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    30 ms
    Sleep
    6.7 h
    Steps
    6,624
    Resting HR
    87 bpm
    Daily log: GI score 56, nutritional resilience 39, adherence 61.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0300719%S0985
    P-0314220%S1584
    P-0308720%S0483
    P-0304219%S1583
    P-0332919%S1883
    P-0350019%S1983
    P-0332419%S1482
    P-0305419%S0382
    P-0344619%S0381
    P-0319019%S0381
    P-0330219%S2081
    P-0345820%S1581